 Hey guys, how you doing? This is Rich from Rich TV Live, and I want to talk to you about Chiron Life Sciences Corp. A lot of you have been asking me, Rich, talk about Chiron, talk about Chiron, talk about Chiron, and I've honestly just have been so busy looking at all these other picks. I have not been looking at Chiron Life Sciences, and I want to apologize for that because they have been on fire. Absolutely on fire from July 31st, 2018 at 67 cents, now at $2.07 in America, and it has been just a darling. K-H-R-N in Canada, K-H-R-N-F in America, and I want to mark it here as well. It has been an absolute beast. So, Chiron Life Sciences, look at this, MacD here. The blue line is pointing up, the orange line is pointing up, the red lines are pointing above the line here, so that's a lot of buying pressure here. This baby had a massive day today, up 13.93%. On a day that was a graveyard, everything else was red pretty much, except for Chiron Life Sciences. I am this as well, which is one that I told you guys about, but this is one that I've been kind of sleeping on. It has had a massive run here from October at $1.15, now to $2.78, up over 100%. And if we look on bar chart, it says here it's a 96% buy with the strongest short-term outlook on maintaining the current direction. Long-term, the trend strength is maximal. Long-term indicators fully support a continuation of this trend. So, there's a lot of momentum here for Chiron Life Sciences Corp. And right here it says Chiron Life Sciences Corp is a Canadian-based company involved in cultivating, producing and distributing THC and CBD medical cannabis extracts. Some of the potential uses for the medicinal cannabis are disease treatment, pain relief and disease prevention. That doesn't tell the whole story, they're actually based out of Columbia and they're doing a lot of work out of Columbia and out of Latin America. But take a look at this, they're up 143% since December 6th, 82% since January 16th. Wow, that's unbelievable. They need our attention, okay? We need to put our eyes on Chiron. And bam, I see this news today. Chiron, or the company, KHRN TSX Venture Exchange in Canada, KHRNF in America on the OTCQB. And in Germany, under A2JMZC is pleased to announce that it has entered into an agreement with Catacord Genuity Corp and BMO Capital Markets as co-lead underwriters and joint bookrunners. And including CoreMark Security's Inc. together the underwriters, under which the underwriters have agreed to purchase 9.1 million common shares of the company on a bot-deal basis pursuant to a short-form prospectus offering subject to all required regulatory approvals at a price per common share of $2.20 for gross proceeds of 20 million, 20,000, otherwise known as the offering. The company has also granted the underwriters an over-allotment option, the over-allotment option to purchase up to an additional 15% of the common shares at the issue price, exercisable in a whole or in part at any time or up to 30 days following the closing of the offering. If this option is exercised in full, the company will receive an additional $3,000,000 in gross proceeds for total aggregate gross proceeds of $23,000,000. The company intends to use the net proceeds of the offering to expand the company's operating capacity and for working capital requirements and other general corporate purposes. I believe this is huge news for this company and this is going to give it more capital to grow. In connection with the offering, the company has agreed to pay the underwriters a cash commission equal to 6% of the gross proceeds raised from the offering, including on any exercise of the over-allotment option and non-transferable broker warrants equal to 6% of the common shares sold under the offering, including on any exercise of the over-allotment option. Each broker warrant will be exercisable at the issuer price to acquire one common share for a period of 24 months following the closing of the offering. The closing date of the offering is scheduled to be on or about February 28, 2019 and is subject to certain conditions, including but not limited to the receipt of all necessary approvals, including the approval of the TSX Venture Exchange and the applicable securities regulatory authorities. This is where I need you guys to really pay attention. Kiron is positioned to be the dominant integrated medical cannabis company in Latin America as I told you. Kiron has core operations in Colombia and is fully licensed in the country for the cultivation, production, domestic distribution and international export of both THC and CBD medical cannabis. In May 2018, Kiron listed on the TSX-V becoming one of the first Colombian-based medical cannabis companies to trade on any exchange globally. With a focus regional strategy and patient-oriented approach, Kiron combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription and brand loyalty to address priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market for over 620 million people. Kiron is led by co-founder and chief executive officer Alvaro Torres, together with an experienced executive team and knowledgeable board directors that includes former president of Mexico, Vicente Fox. Wow. I mean this could be huge. These guys have been on an epic run. I apologize, Kiron, for not giving you the attention you deserve. You have been one of the hottest stocks and I haven't given you the attention I am giving it to now. Guys, remember Rich TV Live is strictly for education and entertainment purposes. Always do your due diligence. Always do your research before you invest in anything that we talk about here on Rich TV Live. You can find the news, stocks, you want to holler at your boy, contact your boy, follow your boy everywhere. It's true. And Kiron Life Sciences has been an absolute dream. It's been on fire. What do you guys think? If you like this video, smash the like button. Comment down below. Share the video everywhere. If I win and you win, we all win. It's true. So why not win? Kiron Life Sciences, a big winner up 13% on a day when everything else is red. Kiron Life Sciences was up almost 14% and you heard it here first from your boy Rich. Thanks to you, the people bringing Kiron to my attention. Saying Rich, talk about Kiron Rich. They're so good, Rich. Rich, Rich, Rich. I hear you guys. Okay guys, I'm out. Kiron Life Sciences. Put on your watch list. Put on your radar. I'm out. Peace.